Research Progress and Perspectives of Antibody-drug Conjugates Targeting
Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer

Research Progress and Perspectives of Antibody-drug Conjugates Targeting
Trophoblast Cell Surface Antigen-2 in Advanced Non-small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) remains a significant global health burden, and there is an urgent need for new treatment options. Trophoblast cell surface antigen-2 (TROP-2), a target closely associated with NSCLC prognosis, has become a research hotspot in recent years. Notably, TROP-2-targeted...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingyan XU, Jiaqi LIU, Shiqi MEI, Qing ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
actionable genomic alterations
antibody-drug conjugates
trophoblast cell surface antigen-2
drug therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.101.25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items